Pear Therapeuticsfiled for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Delaware and intends to pursue a sale of the business or its assets.
“We also announced a reduction in force, including me,”
Pear Therapeutics marketed the reSET and reSET-O prescription cognitive behavioral therapy-based digital therapeutics (PDTs) for drug and opioid addiction as well as the Somryst digital therapeutic to treat insomnia via cognitive behavioral therapy techniques